Kane made it into the top ten biotech companies of 2011:

01 / Amyris

For deploying novel methods to fight an old foe, the malaria parasite

02 / Omeros

For a new test to identify potential drug receptors

03 / Synthetic Genomics

For its multi-application approach to synthetic microbes

04 / Galapagos

For its super-efficient drug pipeline

05 / Amgen

For a new osteoporosis drug that could also battle hormonal breast cancer

06 / Fate Therapeutics

For devising an innovative way to test drugs on human cells

07 / NovaBay

For antibiotic-like compounds that fight their battles by mimicking the human immune system

08 / Oncogenex

For protein-targeting, chemo-boosting cancer treatments

09 / Myelin Repair Foundation

For its unorthodox, highly collaborative approach to drug development

10 / Kane Biotech

For a wound-care spray that could aid and speed healing